Endoscopy 2020; 52(S 01): S160
DOI: 10.1055/s-0040-1704493
ESGE Days 2020 ePoster Podium presentations
Friday, April 24, 2020 09:30 – 10:00 Upper GI: Interesting clinical cases ePoster Podium 1
© Georg Thieme Verlag KG Stuttgart · New York

UPPER GASTROINTESTINAL BLEEDING SECONDARY TO BURKITT LYMPHOMA, AN UNCOMMON BUT VERY AGGRESSIVE CAUSE OF GASTRIC CANCER

Authors

  • P Florez-Diez

    1   Hospital Universitario Central de Asturias, Digestive, Oviedo, Spain

  • N Rodriguez-Ferreiro

    1   Hospital Universitario Central de Asturias, Digestive, Oviedo, Spain

  • V Jimenez-Beltran

    1   Hospital Universitario Central de Asturias, Digestive, Oviedo, Spain

  • M Fraile-Lopez

    1   Hospital Universitario Central de Asturias, Digestive, Oviedo, Spain

  • O Gonzalez-Bernardo

    1   Hospital Universitario Central de Asturias, Digestive, Oviedo, Spain

  • A Suarez-Noya

    1   Hospital Universitario Central de Asturias, Digestive, Oviedo, Spain

  • C Del Caño-Cerdan

    1   Hospital Universitario Central de Asturias, Digestive, Oviedo, Spain

  • A Nieto-Jara

    1   Hospital Universitario Central de Asturias, Digestive, Oviedo, Spain

  • L Carballo-Folgoso

    1   Hospital Universitario Central de Asturias, Digestive, Oviedo, Spain

  • M Celada-Sendino

    1   Hospital Universitario Central de Asturias, Digestive, Oviedo, Spain

  • A Gejo-Beneitez

    1   Hospital Universitario Central de Asturias, Digestive, Oviedo, Spain
Further Information

Publication History

Publication Date:
23 April 2020 (online)

Also available at
 
 

    Lymphoma is the second most common type of gastric cancer, especially MALT and diffuse large B cells lymphomas. A very rare but highly aggressive lymphoma is Burkitt lymphoma. Man, 72 years with epigastralgia, melena and anemia. In urgent gastroscopy, a large excavated ulcer is observed on the underside of the antrum (1-3). Biopsies show CD20+/bcl-6+/CD10+ lymphoid cells on the lamina propria, over-expression of c-myc and Ki67>90%, compatible with Burkitt lymphoma. PET/CT (4) shows large gastric hypermetabolic mass, with multiple intra-abdominal nodules. Chemotherapy (R-DA-EPOCH scheme) achieves complete metabolic remission in PET/CT at the end of treatment (5).